Zsófia Sztupinszki
Zsófia Sztupinszki
Boston Children's Hospital
Verified email at childrens.harvard.edu
Title
Cited by
Cited by
Year
A comprehensive overview of targeted therapy in metastatic renal cell carcinoma
Z Mihály, Z Sztupinszki, P Surowiak, B Gyorffy
Current cancer drug targets 12 (7), 857-872, 2012
482012
The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer
AM Szász, Q Li, AC Eklund, Z Sztupinszki, A Rowan, AM Tőkés, B Székely, ...
PloS one 8 (2), e56707, 2013
292013
Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines
Z Pénzváltó, B Tegze, AM Szász, Z Sztupinszki, I Likó, A Szendrői, ...
PloS one 8 (3), e59503, 2013
232013
Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors
M Diossy, L Reiniger, Z Sztupinszki, M Krzystanek, KM Timms, C Neff, ...
Annals of Oncology 29 (9), 1948-1954, 2018
162018
Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease
NJ Béres, Z Kiss, Z Sztupinszki, G Lendvai, A Arató, E Sziksz, Á Vannay, ...
Digestive and Liver Disease 49 (4), 378-387, 2017
152017
Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
Z Sztupinszki, B Győrffy
Scientific reports 6, 37169, 2016
142016
High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy
S Leé, K Vargová, I Hizoh, Z Horváth, P Gulácsi-Bárdos, Z Sztupinszki, ...
Thrombosis research 133 (2), 257-264, 2014
122014
Dynamic classification using case‐specific training cohorts outperforms static gene expression signatures in breast cancer
B Győrffy, T Karn, Z Sztupinszki, B Weltz, V Müller, L Pusztai
International journal of cancer 136 (9), 2091-2098, 2015
112015
Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
Z Sztupinszki, M Diossy, M Krzystanek, L Reiniger, I Csabai, F Favero, ...
NPJ breast cancer 4 (1), 1-4, 2018
92018
Validation of rnai silencing efficiency using gene array data shows 18.5% failure rate across 429 independent experiments
G Munkácsy, Z Sztupinszki, P Herman, B Bán, Z Pénzváltó, N Szarvas, ...
Molecular Therapy-Nucleic Acids 5, e366, 2016
92016
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
NJ Birkbak, Y Li, S Pathania, A Greene-Colozzi, M Dreze, ...
Annals of Oncology 29 (4), 903-909, 2018
82018
Detection of molecular signatures of homologous recombination deficiency in prostate cancer with or without BRCA1/2 mutations
Z Sztupinszki, M Diossy, M Krzystanek, J Borcsok, MM Pomerantz, V Tisza, ...
Clinical Cancer Research 26 (11), 2673-2680, 2020
12020
Corrigendum to: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding …
M Diossy, L Reiniger, Z Sztupinszki, M Krzystanek, KM Timms, C Neff, ...
Annals of Oncology 30 (8), 1406-1406, 2019
12019
Strand Orientation Bias Detector (SOBDetector) to remove artifacts from sequencing data of formalin fixed samples
M Diossy, Z Sztupinszki, M Krzystanek, AG Pedersen, AC Eklund, ...
bioRxiv, 386417, 2018
12018
Simplified, low-cost gene expression profiling for the prediction of outcome in breast cancer based on routine histologic specimens
AM Szász, B Ács, E Ágoston, Z Sztupinszki, AM Tőkés, L Szittya, ...
Orvosi hetilap 154 (16), 627-632, 2013
12013
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells
H Duan, S Mansour, R Reed, MK Gillis, B Parent, B Liu, Z Sztupinszki, ...
Journal of Cell Biology 219 (6), 2020
2020
Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer
S Sharad, AA Dillman, ZM Sztupinszki, Z Szallasi, I Rosner, J Cullen, ...
Oncotarget 11 (4), 362, 2020
2020
Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer
S Sharad, ZM Sztupinszki, Y Chen, C Kuo, L Ravindranath, Z Szallasi, ...
Cancers 11 (12), 1995, 2019
2019
46P Prevalence of homologous recombination deficiency (HRD)-related signatures indicates that a wider range of prostate cancer patients may benefit from PARP-inhibitor therapy
Z Sztupinszki, M Diossy, M Krzystanek, J Borcsok, M Pomerantz, V Tisza, ...
Annals of Oncology 30 (Supplement_7), mdz413. 051, 2019
2019
High circulating miR-1247 is a marker for poor prognosis in patients with metastatic colorectal cancer treated with chemotherapy and cetuximab
JV Schou, Z Sztupinszki, JS Johansen, DL Nielsen, B Glimelius, ...
Annals of Oncology 30, v236, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20